In this MEDICA-tradefair.com interview, Max Ostermeier talks about the eyemate system by Implandata Ophthalmic Products, which won the Healthcare Innovation World Cup at MEDICA 2021.
Mr. Ostermeier, what is the eyemate system and how does it work?
Max Ostermeier: Eyemate is a proprietary implant that facilitates remote monitoring and management of glaucoma patients. This eye condition causes elevated intraocular pressure. If left untreated, it damages the optic nerve. Over time, patients experience defects in their peripheral field of vision and if the damage worsens, even permanent vision loss.
When it comes to glaucoma care, there is no lack of ocular hypotensive therapies as there are many oral medications, invasive and non-invasive procedures available. The problem pertains to the monitoring of glaucoma since the eye doctor must measure the intraocular pressure at his/her office. Patients with glaucoma have scheduled follow-up visits every three to six months, which means physicians only get a snapshot into the disease progression.
The eyemate system features a micro-sensor that is implanted in the eye and facilitates self-measurements in the patient's usual living environment. Patients use our proprietary handheld device to make intraocular pressure measurements on their own. The data is then transmitted to our secure database. This allows the eye doctor to remotely monitor the condition and make treatment adjustments based on the patient's current condition at an earlier stage.